Related Experiment Video
Updated: May 15, 2026

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Interleukin-13 signaling and its role in asthma
Efren L Rael1, Richard F Lockey
1From the 1Department of Allergy, Asthma and Immunology, Penn State Hershey Medical Center MCH0401, Hershey, PA; 2University Distinguished Health Professor, Professor of Medicine, Pediatrics & Public Health; Director, Division of Allergy & Immunology, Joy McCann Culverhouse Chair in Allergy & Immunology; World Allergy Organization President; University of South Florida College of Medicine University of South Florida; James A. Haley Veterans' Hospital, Department of A/I (111D), Tampa, FL.
Severe asthma impacts millions globally. Targeting the interleukin-13 pathway shows promise for treating difficult asthma phenotypes unresponsive to standard therapies.
Area of Science:
- Pulmonology and immunology research.
- Focus on respiratory diseases and allergic inflammation.
Background:
- Asthma affects nearly 300 million worldwide.
- Most patients respond to inhaled corticosteroids and beta-adrenergic agonists.
- A significant subset (5-10%) with severe asthma exhibit suboptimal treatment response.
Purpose of the Study:
- Investigate the role of interleukin-13 in severe asthma.
- Explore the interleukin-13 pathway as a therapeutic target for distinct asthma phenotypes.
Main Methods:
- Review of current asthma treatment paradigms.
- Analysis of the biological functions of interleukin-13 in airway inflammation.
- Examination of research on interleukin-13 pathway inhibitors.
Main Results:
- Interleukin-13 is a key mediator in IgE synthesis, mucus production, airway hyperresponsiveness, and fibrosis.
- The interleukin-13 pathway's central role is implicated in various asthma phenotypes.
- Current therapies are less effective in specific asthma subgroups.
Conclusions:
- The interleukin-13 pathway represents a promising therapeutic target for severe asthma.
- Targeting interleukin-13 may offer new treatment options for patients with refractory asthma phenotypes.
- Further research into interleukin-13 modulation is warranted for personalized asthma management.
Related Concept Videos
Asthma I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Asthma-I: Introduction
Asthma III: Clinical Manifestations
